# Etoposide

NDC: 0378-3266
Generic name: etoposide
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20011022

FDA application: ANDA075635

## Active ingredients

- ETOPOSIDE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-3266"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-3266
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=508a418e-985f-4208-9324-2230655bb5c2